InfuSystems Holdings Inc INFU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INFU is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $7.87
- Day Range
- $7.57–7.87
- 52-Week Range
- $7.57–11.44
- Bid/Ask
- $6.88 / $8.76
- Market Cap
- $161.82 Mil
- Volume/Avg
- 30,441 / 47,364
Key Statistics
- Price/Earnings (Normalized)
- 268.58
- Price/Sales
- 1.35
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.78%
Company Profile
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 516
- Website
- http://www.infusystem.com
Comparables
Valuation
|
Metric
|
INFU
|
LUNG
|
OM
|
|---|---|---|---|
Price/Earnings (Normalized) | 268.58 | — | — |
Price/Book Value | 3.19 | 2.45 | 1.04 |
Price/Sales | 1.35 | 4.16 | 0.97 |
Price/Cash Flow | 10.15 | — | — |
Price/Earnings
INFU
LUNG
OM
Financial Strength
|
Metric
|
INFU
|
LUNG
|
OM
|
|---|---|---|---|
Quick Ratio | 1.28 | 5.62 | 4.27 |
Current Ratio | 1.95 | 6.50 | 5.26 |
Interest Coverage | 1.85 | −19.37 | −13.39 |
Quick Ratio
INFU
LUNG
OM
Profitability
|
Metric
|
INFU
|
LUNG
|
OM
|
|---|---|---|---|
Return on Assets (Normalized) | 3.11% | −22.61% | −39.03% |
Return on Equity (Normalized) | 6.35% | −31.80% | −72.89% |
Return on Invested Capital (Normalized) | 5.58% | −25.75% | −44.98% |
Return on Assets
INFU
LUNG
OM
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Zyxkwtfwjj | Yfqg | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Ftkrhtzz | Ttfzf | $67.6 Bil | |
ALC
| Alcon Inc | Tbbwlnlg | Xhryb | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Lgckfplwrq | Lpxq | $29.7 Bil | |
WST
| West Pharmaceutical Services Inc | Xgjscnbfsd | Vxlr | $28.6 Bil | |
RMD
| ResMed Inc | Hfdrllqbz | Ljdxg | $27.0 Bil | |
BAX
| Baxter International Inc | Ftgdpcgk | Bqrzqmc | $20.9 Bil | |
COO
| The Cooper Companies Inc | Nzglbdtc | Lmqllhp | $18.2 Bil | |
HOLX
| Hologic Inc | Rcfmhhcn | Ktxgd | $17.9 Bil | |
TFX
| Teleflex Inc | Nzwv | Vybpp | $9.9 Bil |